Sobrerol in the Treatment of Secretory Otitis Media in Childhood-Reference-Cited by-同舟云学术

Sobrerol in the Treatment of Secretory Otitis Media in Childhood

Published:1989-05 Issue:3 Volume:17 Page:277-286
ISSN:0300-0605
Container-title:Journal of International Medical Research
language:en
Short-container-title:J Int Med Res

Author:

Bellussi L.¹,Bernocchi D.²,Ciferri G.¹,Manini G.²,Passali D.¹

Affiliation:

1. Medical School, Ear, Nose and Throat Department, University of Aquila, Aquila, Italy

2. Medical Department, Camillo Corvi SpA, Piacenza, Italy

Abstract

The therapeutic activity and tolerability of sobrerol, a muco-active agent, were evaluated in 30 children (aged 5–10 years) with secretory otitis media. The drug was administered once daily by inhalation for 10 days consecutively at a dose of 40 mg/3 ml. Clinical assessments showed a significant improvement in the objective measures together with good tolerability. Moreover, sobrerol was shown to improve impedance values; this is an important aspect of the modifications induced by this drug in diseases involving the ear.

Publisher

SAGE Publications

Subject

Biochemistry (medical),Cell Biology,Biochemistry,General Medicine

Link

http://journals.sagepub.com/doi/pdf/10.1177/030006058901700311

Reference18 articles.

1. Pharmacokinetics of Sobrerol in chronic bronchitis

2. Action of Sobrerol on Mucociliary Transport

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sobrerol: New Perspectives to Manage Patients with Frequent Respiratory Infections;Children;2023-07-12

2. Selective Catalytic Epoxidation–Hydration of α-Pinene with Hydrogen Peroxide to Sobrerol by Durable Ammonium Phosphotungstate Immobilized on Imidazolized Activated Carbon;Nanomaterials;2023-05-05

3. Dietary Risk Factors and Eating Behaviors in Peripheral Arterial Disease (PAD);International Journal of Molecular Sciences;2022-09-16

4. Biomimetic conversion of α-pinene with H2O2 to sobrerol over V2O5: Dihydroxylation by a peroxo vanadium peracid vectoring gentle synergistic oxidation;Catalysis Communications;2020-07

5. Mucoactive Agents in the Therapy of Upper Respiratory Airways Infections: Fair to Describe Them Just as Mucoactive?;Clinical Medicine Insights: Ear, Nose and Throat;2019-01